Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Baxter
AstraZeneca
Express Scripts
Boehringer Ingelheim
Medtronic

Last Updated: August 11, 2022

Investigational Drug Information for SCY-078


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug SCY-078?

SCY-078 is an investigational drug.

There have been 15 clinical trials for SCY-078. The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2017.

The most common disease conditions in clinical trials are Candidiasis, Candidiasis, Vulvovaginal, and Candidiasis, Invasive. The leading clinical trial sponsors are Scynexis, Inc., Clinical Network Services (CNS) Pty Ltd, and Inncelerex.

There are four US patents protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for SCY-078
TitleSponsorPhase
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral FluconazoleScynexis, Inc.Phase 3
ADME Study of [14C]-Ibrexafungerp in Healthy Male SubjectsInncelerexPhase 1
ADME Study of [14C]-Ibrexafungerp in Healthy Male SubjectsScynexis, Inc.Phase 1

See all SCY-078 clinical trials

Clinical Trial Summary for SCY-078

Top disease conditions for SCY-078
Top clinical trial sponsors for SCY-078

See all SCY-078 clinical trials

US Patents for SCY-078

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SCY-078 See Plans and Pricing Salts and polymorphs of SCY-078 SCYNEXIS, INC. (Research Triangle Park, NC) See Plans and Pricing
SCY-078 See Plans and Pricing Salts and polymorphs of SCY-078 SCYNEXIS, INC. (Jersey City, NJ) See Plans and Pricing
SCY-078 See Plans and Pricing Salts and polymorphs of SCY-078 SCYNEXIS, INC. (Jersey City, NJ) See Plans and Pricing
SCY-078 See Plans and Pricing Antifungal agents Merck Sharp & Dohme Corp. (Rahway, NC) Seynexis, Inc. (Research Triangle Park, NC) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SCY-078

Drugname Country Document Number Estimated Expiration Related US Patent
SCY-078 Denmark DK3247711 2035-01-19 See Plans and Pricing
SCY-078 Eurasian Patent Organization EA036874 2035-01-19 See Plans and Pricing
SCY-078 Eurasian Patent Organization EA201791645 2035-01-19 See Plans and Pricing
SCY-078 European Patent Office EP3247711 2035-01-19 See Plans and Pricing
SCY-078 Spain ES2913111 2035-01-19 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
AstraZeneca
Express Scripts
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.